News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
78 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18052)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (119)
3 (12)
4 (242)
5 (269)
6 (241)
7 (243)
8 (78)
9 (2)
10 (3)
11 (232)
12 (312)
13 (213)
14 (243)
15 (110)
16 (8)
17 (9)
18 (85)
19 (267)
20 (246)
21 (243)
22 (113)
23 (7)
24 (12)
25 (220)
26 (276)
27 (239)
28 (312)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Pharm Country
Consumers Turn to CBD Products Due to their Non-Psychoactive Nature
Cannabidiol, or CBD-based, products are appearing everywhere throughout the U.S., whether it’s for healthcare and wellness, beauty, pets, medicinal, or even just purely recreational use.
February 8, 2019
·
13 min read
BioCapital
Pharmacists for Healthier Lives Continues to Grow as Four Additional State Pharmacy Associations Join the Coalition
Pharmacists for Healthier Lives - a coalition of pharmacy organizations seeking to raise the profile of pharmacy as an essential healthcare profession - announced today that four state pharmacy associations have joined the campaign.
February 8, 2019
·
2 min read
Supreme Cannabis simplifies trading in the U.S. with DTC eligibility
The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is pleased to announce it has received approval from The Depository Trust Company (“DTC”) of New York to make the Company’s shares DTC eligible.
February 8, 2019
·
4 min read
ZEISS Elyra 7 with Lattice SIM introduced
ZEISS is introducing ZEISS Elyra 7 with Lattice SIM, a new flexible platform for fast and gentle 3D superresolution. Lattice SIM expands the possibilities of structured illumination microscopy (SIM): illuminating the sample with a lattice pattern rather than grid lines gives higher contrast and allows a more robust image reconstruction.
February 8, 2019
·
2 min read
Policy
RM LAW Announces Class Action Lawsuit Against Lexicon Pharmaceuticals, Inc.
RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Lexicon Pharmaceuticals, Inc. between March 11, 2016, and January 17, 2019, inclusive.
February 8, 2019
·
2 min read
Pharm Country
Revolutionary GAINSWave® Treatment for Erectile Dysfunction Offered by Dr. Eliot Y. Ghatan, MD, PC in New York
Dr. Eliot Y. Ghatan, MD, PC is making waves in the medical world of sexual wellness by joining the GAINSWave® movement to offer GAINSWave!
February 8, 2019
·
2 min read
Deals
Portage Biotech Inc. - CSE to Issue Final Bulletin Regarding SalvaRx Acquisition
Portage Biotech Inc. wishes to announce that due to an oversight, closing of the SalvaRx Acquisition was completed prior to obtaining final CSE approval.
February 8, 2019
·
1 min read
Policy
Axogen Shareholder Alert: Claimsfiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Axogen, Inc. - Axgn
ClaimsFiler reminds investors that they have until March 11, 2019 to file lead plaintiff applications in a securities class action lawsuit against AxoGen, Inc., if they purchased the Company’s securities in connection with its November 2017 or May 2018 secondary public offering or between August 7, 2017 and December 18, 2018, inclusive.
February 8, 2019
·
1 min read
Previous
8 of 8